Trabectedin Versus Pazopanib within The Treatment of Advanced, Metastatic, Leiomyosarcomas in Scotland- Results of A Cost-Effectiveness Analysis Following A Matching Adjusted Indirect Comparison
Abstract
Authors
JM Fernandez B Garcia San Andrés